Cargando…

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability

Anti-CD20 monoclonal antibody rituximab is an approved adjuvant treatment, in combination with oral corticosteroids, for patients with pemphigus vulgaris, a severe and potentially life-threatening autoimmune blistering skin disorder. Updated approaches to the management of pemphigus vulgaris support...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciolfi, Christian, Sernicola, Alvise, Alaibac, Mauro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651071/ https://www.ncbi.nlm.nih.gov/pubmed/36387051 http://dx.doi.org/10.2147/PPA.S350756

Ejemplares similares

Cutaneous Lymphoma and Antibody-Directed Therapies
por: Sernicola, Alvise, et al.
Publicado: (2023)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders
por: Sernicola, Alvise, et al.
Publicado: (2023)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

How to Deal With Post-viral Cutaneous Eruptions in the Era of Coronavirus Infection
por: Sernicola, Alvise, et al.
Publicado: (2020)

Editorial: Cutaneous manifestations of systemic disease
por: Sernicola, Alvise, et al.
Publicado: (2023)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity
por: Russo, Irene, et al.
Publicado: (2020)

Neoplastic and Autoimmune Comorbidities in Patients with Primary Cutaneous B-Cell Lymphoma
por: Mazzetto, Roberto, et al.
Publicado: (2023)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
por: Chen, D.M., et al.
Publicado: (2019)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Management of Pemphigus Vulgaris
por: Cholera, Mimansa, et al.
Publicado: (2016)

Granulocyte Apheresis: Can It Be Associated with Anti PD-1 Therapy for Melanoma?
por: Sernicola, Alvise, et al.
Publicado: (2022)

Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris
por: Hutchison, Dana M., et al.
Publicado: (2022)

Hepatitis B reactivation in patients with pemphigus vulgaris after immunosuppressive therapy including rituximab
por: Yoo, Dae San, et al.
Publicado: (2020)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
por: Schauer, Franziska, et al.
Publicado: (2020)

Pemphigus vulgaris
por: Tamgadge, Sandhya, et al.
Publicado: (2011)

Pemphigus vulgaris
por: Porro, Adriana Maria, et al.
Publicado: (2019)

Emerging treatment options for the management of pemphigus vulgaris
por: Kridin, Khalaf
Publicado: (2018)

Pemphigus vulgaris - approach and management
por: Popescu, Ioana Adriana, et al.
Publicado: (2019)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
por: Khatib, Mohamad Y., et al.
Publicado: (2020)

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
por: Fenizia, Claudio, et al.
Publicado: (2023)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
por: Dolenc‐Voljč, Mateja, et al.
Publicado: (2022)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
por: Corral, Isabela Soubhia, et al.
Publicado: (2013)

The role of pentraxin 3 in pemphigus vulgaris
por: Halil Yavuz, Ibrahim, et al.
Publicado: (2019)

Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review
por: Tham, Heng L., et al.
Publicado: (2020)

Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Di Lernia, Vito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0jc59td782pis59k8qicnece8